Janumet 50/1000

About this medicine
Details marketing authorisation

This medicine has been approved for use for the indication as stated here. Availability: Uitsluitend recept

About this medicine

Active substance:	METFORMINEHYDROCHLORIDE 1000 mg/stuk SAMENSTELLING overeenkomend met METFORMINE 779.6 mg/stuk SITAGLIPTINEFOSFAAT 1-WATER 64.25 mg/stuk SAMENSTELLING overeenkomend met SITAGLIPTINE 50 mg/stuk
Excipients:	CELLULOSE, MICROKRISTALLIJN (E 460(i)) IJZEROXIDE ROOD (E 172) IJZEROXIDE ZWART (E 172) MACROGOL 3350 NATRIUMLAURILSULFAAT NATRIUMSTEARYLFUMARAAT POLYVINYLALCOHOL (E 1203) POVIDON K 30 (E 1201) TALK (E 553b) TITAANDIOXIDE (E 171)

externe link Information about Metformin And Sitagliptin on Farmacotherapeutisch Kompas

SmPC, label and patient information leaflet

Alert: this document may contain the product information for several strengths and/or pharmaceutical forms.

Product page on the website of the European Medicines Agency

Patient information

You can find an extensive description of the efficacy and possible adverse events of this medicine in the patient information leaflet and summary of the product characteristics.

Patient information

externe link Information about Metformin And Sitagliptin on Lareb.nl

Are you experiencing adverse events? Please report to the Adverse Events Centre Lareb. externe link I would like to report an adverse event

Do you need more information on sickness and health? Take a look at externe link Thuisarts.nl.

Patient information

You can find an extensive description of the efficacy and possible adverse events of this medicine in the patient information leaflet and summary of the product characteristics.